# Anti-psychotic Medication (New Use) Weight Loss Study

> **NCT01272752** · PHASE2 · WITHDRAWN · sponsor: **Avera McKennan Hospital & University Health Center**

## Conditions studied

- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** IHBG-10
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01272752
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study did not get started.
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01272752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01272752, "Anti-psychotic Medication (New Use) Weight Loss Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01272752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*